Diagnostic and Evaluation of Hepato-pancreatico-biliary Disease With MRI

University of Zurich (UZH)

Status: Unknown

Conditions: Pancreas Disease; Liver Diseases

Treatments: Diagnostic Test: Magnetic resonance imaging

Study type: Observational

Funder types: Other

Identifiers

NCT04701567

BASEC ID 2020-01313

Details and patient eligibility

About

This is a retrospective review of images from patient data. There is no recruitment necessary for this study.

Research Question: Can advanced multiparametric MRI techniques improve the detection and characterization of focal and diffuse liver disease, accurately assess treatment response and predict patient outcomes based on longitudinal monitoring? Hypotheses: Advanced multiparametric MRI techniques improve the detection, characterization and response assessment of focal and diffuse liver disease and can predict serious liver related outcomes.

Enrollment: 2,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with suspicion for or diagnosed focal and/or diffuse liver or pancreatic disease who underwent MRI of the abdomen.
• 18 years of age and older.

Exclusion criteria

• Age less than 18 years.
• Lack of MRI of the abdomen.
• Inadequate image quality.
• Documented rejection to participate in research studies

Trial design

2,000 participants in 2 patient groups

Liver disease

Treatment:

Diagnostic Test: Magnetic resonance imaging

Pancreatic disease

Treatment:

Diagnostic Test: Magnetic resonance imaging